Nuevo fármaco retrasaría avance del alzhéimer

from Camilo · host CNN en Español

El fármaco experimental Lecanemab se muestra como un "potencial" tratamiento para pacientes diagnosticados con el mal de Alzheimer. No obstante, los hallazgos plantean algunas preocupaciones de seguridad debido a su asociación con ciertos eventos adversos graves que se produjeron en algunos de los pacientes que participaron en el estudio. Para conocer sobre cómo CNN protege la privacidad de su audiencia, visite CNN.com/privacidad Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Dec 3, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Nuevo fármaco retrasaría avance del alzhéimer

0:00 35:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Camilo?

This episode is 35 minutes long.

When was this Camilo episode published?

This episode was published on December 3, 2022.

Can I download this Camilo episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!